NM_006846.4:c.2132G>A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_006846.4(SPINK5):​c.2132G>A​(p.Arg711Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.6 in 1,613,600 control chromosomes in the GnomAD database, including 295,948 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.54 ( 23528 hom., cov: 32)
Exomes 𝑓: 0.61 ( 272420 hom. )

Consequence

SPINK5
NM_006846.4 missense

Scores

15

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7O:1

Conservation

PhyloP100: 1.18

Publications

37 publications found
Variant links:
Genes affected
SPINK5 (HGNC:15464): (serine peptidase inhibitor Kazal type 5) This gene encodes a multidomain serine protease inhibitor that contains 15 potential inhibitory domains. The encoded preproprotein is proteolytically processed to generate multiple protein products, which may exhibit unique activities and specificities. These proteins may play a role in skin and hair morphogenesis, as well as anti-inflammatory and antimicrobial protection of mucous epithelia. Mutations in this gene may result in Netherton syndrome, a disorder characterized by ichthyosis, defective cornification, and atopy. This gene is present in a gene cluster on chromosome 5. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2015]
FBXO38-DT (HGNC:55589): (FBXO38 divergent transcript)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=2.2599243E-6).
BP6
Variant 5-148118456-G-A is Benign according to our data. Variant chr5-148118456-G-A is described in ClinVar as Benign. ClinVar VariationId is 260049.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.63 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SPINK5NM_006846.4 linkc.2132G>A p.Arg711Gln missense_variant Exon 23 of 33 ENST00000256084.8 NP_006837.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SPINK5ENST00000256084.8 linkc.2132G>A p.Arg711Gln missense_variant Exon 23 of 33 1 NM_006846.4 ENSP00000256084.7

Frequencies

GnomAD3 genomes
AF:
0.543
AC:
82423
AN:
151928
Hom.:
23505
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.353
Gnomad AMI
AF:
0.591
Gnomad AMR
AF:
0.640
Gnomad ASJ
AF:
0.540
Gnomad EAS
AF:
0.470
Gnomad SAS
AF:
0.505
Gnomad FIN
AF:
0.633
Gnomad MID
AF:
0.535
Gnomad NFE
AF:
0.629
Gnomad OTH
AF:
0.545
GnomAD2 exomes
AF:
0.594
AC:
148169
AN:
249534
AF XY:
0.589
show subpopulations
Gnomad AFR exome
AF:
0.349
Gnomad AMR exome
AF:
0.742
Gnomad ASJ exome
AF:
0.550
Gnomad EAS exome
AF:
0.461
Gnomad FIN exome
AF:
0.641
Gnomad NFE exome
AF:
0.622
Gnomad OTH exome
AF:
0.596
GnomAD4 exome
AF:
0.606
AC:
886363
AN:
1461554
Hom.:
272420
Cov.:
55
AF XY:
0.604
AC XY:
438856
AN XY:
727090
show subpopulations
African (AFR)
AF:
0.345
AC:
11562
AN:
33474
American (AMR)
AF:
0.726
AC:
32486
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.550
AC:
14366
AN:
26124
East Asian (EAS)
AF:
0.437
AC:
17349
AN:
39680
South Asian (SAS)
AF:
0.509
AC:
43919
AN:
86252
European-Finnish (FIN)
AF:
0.642
AC:
34265
AN:
53404
Middle Eastern (MID)
AF:
0.534
AC:
3077
AN:
5766
European-Non Finnish (NFE)
AF:
0.624
AC:
694030
AN:
1111754
Other (OTH)
AF:
0.585
AC:
35309
AN:
60376
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
20326
40652
60979
81305
101631
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
18426
36852
55278
73704
92130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.543
AC:
82486
AN:
152046
Hom.:
23528
Cov.:
32
AF XY:
0.542
AC XY:
40310
AN XY:
74308
show subpopulations
African (AFR)
AF:
0.354
AC:
14657
AN:
41460
American (AMR)
AF:
0.640
AC:
9782
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.540
AC:
1872
AN:
3468
East Asian (EAS)
AF:
0.469
AC:
2414
AN:
5144
South Asian (SAS)
AF:
0.506
AC:
2438
AN:
4820
European-Finnish (FIN)
AF:
0.633
AC:
6699
AN:
10580
Middle Eastern (MID)
AF:
0.517
AC:
152
AN:
294
European-Non Finnish (NFE)
AF:
0.629
AC:
42781
AN:
67984
Other (OTH)
AF:
0.546
AC:
1153
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1881
3761
5642
7522
9403
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
716
1432
2148
2864
3580
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.594
Hom.:
93414
Bravo
AF:
0.536
TwinsUK
AF:
0.633
AC:
2346
ESP6500AA
AF:
0.381
AC:
1456
ESP6500EA
AF:
0.616
AC:
5070
ExAC
AF:
0.583
AC:
70397
Asia WGS
AF:
0.528
AC:
1832
AN:
3478
EpiCase
AF:
0.617
EpiControl
AF:
0.616

ClinVar

Significance: Benign
Submissions summary: Benign:7Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Jan 24, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 91% of patients studied by a panel of primary immunodeficiencies. Number of patients: 80. Only high quality variants are reported.

Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency

PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Netherton syndrome Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:1Other:1
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

GenomeConnect, ClinGen
Significance:not provided
Review Status:no classification provided
Collection Method:phenotyping only

Variant interpreted as Benign and reported on 04-27-2020 by Lab or GTR ID 500031. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. This variant was reported in an individual referred for clinical diagnostic genetic testing.

Ichthyosis linearis circumflexa Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.70
T
BayesDel_noAF
Benign
-0.63
CADD
Benign
12
DANN
Benign
0.94
DEOGEN2
Benign
0.0
.;.;.;T
Eigen
Benign
-0.85
Eigen_PC
Benign
-0.85
LIST_S2
Benign
0.66
T;T;T;T
MetaRNN
Benign
0.0000023
T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.7
L;L;.;L
PhyloP100
1.2
PrimateAI
Benign
0.24
T
PROVEAN
Benign
-1.0
N;N;N;N
Sift
Benign
0.17
T;T;T;T
Sift4G
Benign
0.17
T;D;T;D
Vest4
0.11
ClinPred
0.0050
T
GERP RS
3.0
Varity_R
0.043
gMVP
0.42
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3777134; hg19: chr5-147498019; COSMIC: COSV56248983; API